DOC
Healthpeak Properties, Inc.
There isn't enough reported data to score DOC yet.
OPEN
Opendoor Technologies Inc.
There isn't enough reported data to score OPEN yet.
DOC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
DOC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for real estate companies like DOC.
OPEN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
OPEN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for real estate companies like OPEN.
DOC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 28x | $15.15 | -25% |
| Current | 37x | $20.12 | — |
| Fair | 44x | $23.94 | +19% |
| Expensive | 66x | $35.54 | +77% |
| Forward | 123x | $20.12 | — |
Historical ranges are pointers, not guarantees.
DOC's PE is 37x, but its earnings don't support one, so it isn't a reliable read right now.
OPEN PE Valuation
OPEN has no meaningful PE right now: it lost money over the past year.
DOC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect DOC's earnings and profitability to decline, with its revenue holding steady.
OPEN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
OPEN has the edge over DOC on the outlook, with more favorable revenue and profitability expectations.
DOC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.16 | -70% |
| Q3 2026 | $0.54 | +$0.58 |
| Q2 2026 | $0.35 | +40% |
| Q1 2026 | $0.32 | -22% |
| Q4 2025 | $0.10 | -72% |
| Q3 2025 | -$0.04 | -109% |
| Q2 2025 | $0.25 | -47% |
| Q1 2025 | $0.41 | +17% |
| Q4 2024 | $0.36 | -36% |
DOC has the edge over OPEN on earnings quality, reporting a profit while its opponent remains loss making.
OPEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.00 | -$1.56 |
| Q2 2026 | -$1.89 | -$1.46 |
| Q1 2026 | -$1.76 | -$1.24 |
| Q4 2025 | -$1.70 | -$1.14 |
| Q3 2025 | -$0.44 | +$0.09 |
| Q2 2025 | -$0.43 | +$0.15 |
| Q1 2025 | -$0.52 | -$0.10 |
| Q4 2024 | -$0.56 | -$0.14 |
OPEN lost $2.00 per share over the past year, and its loss has widened in each of the last five quarters.
DOC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $820.9M | +16% |
| Q2 2026 | $771.6M | +11% |
| Q1 2026 | $753M | +7.1% |
| Q4 2025 | $719.4M | +3.1% |
| Q3 2025 | $705.9M | +0.8% |
| Q2 2025 | $694.3M | -0.2% |
| Q1 2025 | $702.9M | +16% |
| Q4 2024 | $698M | +26% |
DOC has the edge over OPEN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.1% | -4.3 points |
| Q2 2026 | 4.2% | -1.9 points |
| Q1 2026 | 0.7% | -7.9 points |
| Q4 2025 | 8.2% | +3.9 points |
| Q3 2025 | 7.5% | +2.4 points |
| Q2 2025 | 6.2% | +1.9 points |
| Q1 2025 | 8.6% | +18 points |
| Q4 2024 | 4.3% | -6.1 points |
DOC has the edge over OPEN on profitability, with a higher operating margin.
OPEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1B | +12% |
| Q2 2026 | $883M | -44% |
| Q1 2026 | $720M | -38% |
| Q4 2025 | $736M | -32% |
| Q3 2025 | $915M | -34% |
| Q2 2025 | $1.6B | +3.7% |
| Q1 2025 | $1.2B | -2.4% |
| Q4 2024 | $1.1B | +25% |
OPEN's revenue is recovering but still below its 2022 peak: $1B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18% | -11 points |
| Q2 2026 | -16% | -16 points |
| Q1 2026 | -22% | -17 points |
| Q4 2025 | -20% | -12 points |
| Q3 2025 | -7.4% | -2.6 points |
| Q2 2025 | -0.8% | +3.9 points |
| Q1 2025 | -4.9% | +2.5 points |
| Q4 2024 | -8.7% | +4.6 points |
OPEN's operating margin was −18% last quarter, down 11 points from the same quarter a year ago.
DOC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $354.5M | +13% |
| Q2 2026 | $361.1M | -0.7% |
| Q1 2026 | $260.9M | -6.6% |
| Q3 2025 | $315M | -1% |
| Q2 2025 | $363.5M | +15% |
| Q1 2025 | $279.4M | +83% |
| Q3 2024 | $318.2M | +26% |
| Q2 2024 | $316.2M | +6.2% |
DOC's free cash flow was $1.3B over the past year, up 1.1% from the year before. Free cash flow isn't a meaningful measure for real estate companies like DOC.
OPEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$836M | -294% |
| Q2 2026 | -$723M | -188% |
| Q1 2026 | -$250M | +$33M |
| Q4 2025 | $67M | +$150M |
| Q3 2025 | $432M | +671% |
| Q2 2025 | $821M | +$1.2B |
| Q1 2025 | -$283M | -$97M |
| Q4 2024 | -$83M | +$468M |
OPEN's free cash flow was −$1.7B over the past year, against $887M the year before. Free cash flow isn't a meaningful measure for real estate companies like OPEN.
DOC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -376K shares |
| 1 year | -0.8% | -5.4M shares |
| 3 years | +26% | +142M shares |
| 5 years | +28% | +150M shares |
| Available history | +41% | +200M shares |
DOC has the edge over OPEN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $99,000 |
| Q2 2026 | $100.2M |
| Q1 2026 | $1.4M |
| Q4 2025 | $87,000 |
| Q3 2025 | $17,000 |
| Q2 2025 | $72.1M |
| Q1 2025 | $25M |
| Q4 2024 | $326,000 |
DOC spent $102M buying back its own shares over the past year, up 4.5% from the year before.
OPEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -16.3M shares |
| 1 year | +30% | +220M shares |
| 3 years | +42% | +282M shares |
| 5 years | +61% | +361M shares |
| Available history | +1042% | +866M shares |
OPEN has 949M diluted shares, up 30% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
DOC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.1x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 7.4x | High |
| Q3 2025 | 7.2x | High |
| Q2 2025 | 7.1x | High |
| Q1 2025 | 7.0x | High |
| Q4 2024 | 7.9x | High |
DOC's net debt is about 7.1 years of its operating earnings (EBITDA), about the same as a year ago. Net leverage isn't a meaningful measure for real estate companies like DOC.
OPEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 337.2x | High |
OPEN's net debt is more than 20 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for real estate companies like OPEN.
DOC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.3 | Neutral |
| Stochastic | 37.8 | Neutral |
DOC's weekly RSI is 52 (neutral) and its Stochastic is 38 (neutral).
OPEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.6 | Oversold |
| Stochastic | 1.2 | Oversold |
OPEN's weekly RSI is 21 (oversold) and its Stochastic is 1 (oversold).
DOC PE vs Real Estate Sector
| Metric | DOC | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 24x | 56% above |
| PE % | 32 | 23 | 9 pts above |
DOC is trading at 37x earnings, a 56% premium to the Real Estate sector's median of 24x, though its earnings don't support one.
OPEN PE vs Real Estate Sector
OPEN has no meaningful PE right now: it lost money over the past year.
DOC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.5 | 3% above |
| 20 week MA | $20.6 | 2.4% below |
| 50 week MA | $18.9 | 6.7% above |
| 100 week MA | $18.7 | 7.4% above |
| 200 week MA | $19.6 | 2.8% above |
DOC has the edge over OPEN on trend strength, trading above more of its moving averages.
OPEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.97 | 37% below |
| 20 week MA | $3.00 | 59% below |
| 50 week MA | $4.37 | 72% below |
| 100 week MA | $3.74 | 67% below |
| 200 week MA | $3.13 | 60% below |
OPEN is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
DOC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.0 | $29.8 | -12% |
| 2021 | $29.8 | $35.2 | +18% |
| 2022 | $35.2 | $25.2 | -28% |
| 2023 | $25.2 | $19.8 | -21% |
| 2024 | $19.8 | $20.1 | +1.4% |
| 2025 | $20.1 | $16.1 | -20% |
| 2026 YTD | $16.1 | $20.1 | +25% |
DOC has the edge over OPEN on returns for 2026, with the stronger performance.
OPEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $27.4 | +150% |
| 2021 | $27.4 | $14.9 | -46% |
| 2022 | $14.9 | $1.02 | -93% |
| 2023 | $1.02 | $4.48 | +339% |
| 2024 | $4.48 | $1.67 | -63% |
| 2025 | $1.67 | $6.01 | +260% |
| 2026 YTD | $6.01 | $1.24 | -79% |
OPEN's yearly returns have swung widely, from +339% in 2023 to −93% in 2022. It's down 79% so far in 2026.